The Accutane guys are on a roll.
We posted last month about the defense win on Daubert in the Accutane MDL, and before that about the order excluding “relatedness assessments” as proof of causation in the inflammatory bowel disease cases.
The new news just arrived on Wednesday, August 15. It involves the “psychiatric-track cases.”
In
We have some good news and some bad news.
Okay, if you insist.
First, the good news: It’s Judge Moody’s decision granting the defendants’ Daubert motion to exclude plaintiffs’ general causation expert in the Accutane MDL.
You gotta love America. Just last week, the big news was that a New Jersey state court jury had
Patients taking prescription drugs sometimes have bad reactions. Was the reaction caused by the drug, or was it mere coincidence? Was the nausea caused not by the drug, but by the taco for dinner last night?
For subjects enrolled in clinical trials, both the physicians conducting the trials (the “investigators”) and medical monitors overseeing the
We practice in New Jersey a lot – because so many of our pharmaceuticals clients are based there, and the state’s trial courts have tended to allow plaintiffs from all over the country to file there and avoid removal to federal court in diversity actions. New Jersey also just happens to have one of the